Though rare, some patients using GLP-1 medications have reported eye-related issues, including: Blurred Vision: GLP-1 drugs can impact blood sugar levels, and fluctuations in blood sugar can temporarily cause blurred vision
Consequently, while triple agonists represent an important advancement in obesity pharmacotherapy, their safety, tolerability, and long-term developmental effects in adolescents remain unknown
1 Binding, transducer coupling and signalling mediated by TT-OAD2
Medications that affect fluid balance, like diuretics, require extra attention
The mechanisms underlying weight regain are multifactorial and include metabolic adaptation with decreased energy expenditure, hormonal changes affecting appetite regulation, anatomical alterations such as gastric pouch or stoma dilation, and psychosocial factors including maladaptive eating behaviors
It is calculated that an average North American man will increase his weight by 9.1 kg between 25 and 35 years of age, as a consequence of a mere 0.3% imbalance between energy consumed and energy expended over this period [1]